Sands Capital Management 13F holdings, Q2 2009
Holdings as of June 30, 2009 · filings on SEC EDGAR · latest filing →
Sands Capital Management disclosed 42 US equity positions worth $9.5bn in its Q2 2009 13F filing. The largest position was AAPL at 8.9% of the reported book, followed by AMZN and GOOGLE. Against the Q1 2009 filing, it opened 4 new positions, added to 12 and reduced 23 among the top 42 holdings.
What did Sands Capital Management own in Q2 2009? Top 42 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2009 |
|---|---|---|---|---|---|---|---|
| 1 | AAPL APPLE | Technology | 8.9% | $837.6m | 5,880,792 | -4% | reduced |
| 2 | AMZN AMAZON.COM | Consumer Cyclical | 6.8% | $640.2m | 7,652,562 | -4% | reduced |
| 3 | 6.5% | $614.6m | 1,457,826 | -22% | reduced | ||
| 4 | NATIONAL OILWELL VARCO | 6.4% | $606.4m | 18,567,477 | -5% | reduced | |
| 5 | INTERCONTINENTAL EXCHANGE | 6.0% | $567.6m | 4,968,279 | -21% | reduced | |
| 6 | GENZYME | 5.8% | $549.6m | 9,872,438 | 18% | added | |
| 7 | V VISA INC | Financial Services | 5.6% | $529.8m | 8,508,681 | -4% | reduced |
| 8 | ALLERGAN | 5.4% | $513.3m | 10,788,490 | -14% | reduced | |
| 9 | SLB SCHLUMBERGER | Energy | 5.0% | $476.5m | 8,805,804 | -5% | reduced |
| 10 | QCOM QUALCOMM | Technology | 4.7% | $440.7m | 9,749,571 | 30% | added |
| 11 | MONSANTO | 3.9% | $373.5m | 5,023,745 | 51% | added | |
| 12 | CRM SALESFORCE.COM | Technology | 3.8% | $355.2m | 9,306,432 | 10% | added |
| 13 | FMC TECHNOLOGIES | 3.7% | $349.7m | 9,305,346 | -2% | reduced | |
| 14 | AVGO BROADCOM | Technology | 3.6% | $342.9m | 13,832,385 | -5% | reduced |
| 15 | AMERICA MOVIL SPON | 3.3% | $315.6m | 8,151,557 | -4% | reduced | |
| 16 | CME CME GROUP | Financial Services | 3.3% | $312.5m | 1,004,348 | -4% | reduced |
| 17 | LVS LAS VEGAS SANDS | Consumer Cyclical | 3.3% | $307.4m | 39,115,359 | -8% | reduced |
| 18 | VARIAN MEDICAL SYSTEMS | 2.7% | $251.1m | 7,146,549 | -4% | reduced | |
| 19 | MINDRAY MEDICAL INTL | 2.4% | $227.9m | 8,163,210 | -4% | reduced | |
| 20 | NKE NIKE | Consumer Cyclical | 2.0% | $193.3m | 3,733,436 | – | new |
| 21 | SYK STRYKER | Healthcare | 2.0% | $192.1m | 4,833,685 | -4% | reduced |
| 22 | MCO MOODYS CORP | Financial Services | 1.7% | $163.2m | 6,191,712 | -4% | reduced |
| 23 | IRON MOUNTAIN | 1.7% | $161.1m | 5,603,719 | -4% | reduced | |
| 24 | ABRAXIS BIOSCIENCE | 0.4% | $35.6m | 965,048 | -8% | reduced | |
| 25 | ALCON | 0.3% | $27.1m | 233,125 | 0% | held | |
| 26 | ABBNY ABB LTD | Industrials | 0.2% | $15.8m | 1,001,950 | -0% | held |
| 27 | MELI MERCADOLIBRE | Consumer Cyclical | 0.1% | $13.6m | 504,500 | 0% | held |
| 28 | NUVASIVE | 0.1% | $9.9m | 220,975 | -10% | reduced | |
| 29 | CELG CELGENE | 0.0% | $4.4m | 92,300 | 1% | added | |
| 30 | ST. JUDE MEDICAL | 0.0% | $4.2m | 101,300 | 2% | added | |
| 31 | GILD GILEAD SCIENCES | Healthcare | 0.0% | $4.0m | 84,600 | 14% | added |
| 32 | BMRN BIOMARIN PHARMS | Healthcare | 0.0% | $3.8m | 243,700 | 1% | added |
| 33 | VRTX VERTEX PHARMS | Healthcare | 0.0% | $2.9m | 80,800 | 1% | added |
| 34 | ALNY ALNYLAM PHARMS | Healthcare | 0.0% | $2.7m | 120,000 | 1% | added |
| 35 | CR BARD, INC | 0.0% | $2.6m | 35,300 | – | new | |
| 36 | MYGN MYRIAD GENETICS | Healthcare | 0.0% | $2.3m | 65,700 | – | new |
| 37 | MEDAREX | 0.0% | $2.0m | 240,200 | 1% | added | |
| 38 | HANSEN MEDICAL | 0.0% | $1.9m | 379,133 | 1% | added | |
| 39 | GHDX GENOMIC HEALTHCARE INC | 0.0% | $1.4m | 80,800 | -41% | reduced | |
| 40 | EMC CORP | 0.0% | $321.0k | 24,509 | -100% | reduced | |
| 41 | CSCO CISCO SYSTEMS | Technology | 0.0% | $276.0k | 14,800 | -7% | reduced |
| 42 | MYRIAD PHARMACEUTICALS | 0.0% | $75.0k | 16,150 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.